Hiromi Tabuchi

No ORCID on file · 1 paper in corpus

observational 2019

Three-year safety, efficacy and persistence data following the daily use of mirabegron for overactive bladder in the clinical setting: A Japanese post-marketing surveillance study

Lower urinary tract symptoms ·doi:10.1111/luts.12237

OBJECTIVE: The aim of this study was to report the final 3-year results from a surveillance study evaluating the safety, efficacy, and persistence of mirabegron for treating overactive bladder (OAB) symptoms. METHODS: Patients who had star…